Categories Analysis, Consumer

Ban threat looming large over e-cigarette industry

In the backdrop of six fatalities in the US relating to vaping, the Donald Trump administration may soon impose a blanket ban on e-cigarettes. After a meeting with President Trump, US health secretary Alex Azar said a ban on flavored e-cigarettes may soon be in place, in a move to reign its rampant use.

Several hundred people have been affected by a mysterious lung disorder following the use of these vapors, while six of them have died. The incidents come amidst rising criticism of increasing use of e-cigarettes among teenagers.

juul
Photo by Jordan Whitfield on Unsplash

According to the data collected by the FDA last year, there is a 78% increase in vaping among high school students and a 48% increase among middle school students.

Shares of Altria (NYSE: MO), which owns a 35% stake in popular e-cigarette brand JUUL Labs, fell 0.8% during mid-day trading on Wednesday. The stock has declined 11% since the beginning of this year.

The US Food and Drug Administration (FDA) will prepare a set of guidelines for vapors, which will be finalized in a few weeks.

READ: Tobacco giants Philip Morris and Altria confirm merger talks

Earlier this week, JUUL received a letter of warning from US regulators for promoting its products as a safer alternative to the tobacco counterparts. The firm had not obtained approval from the FDA before making the claim. The company management had said it would cooperate with the concerns raised by the officials.

JUUL needs to respond to the FDA within 15 days.   

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top